Guillain-Barré syndrome related to COVID-19 infectionPaola Alberti, Carlo Ferrarese, Maria Luisa Piatti et al.|Neurology Neuroimmunology & Neuroinflammation|2020Cited by 340
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single‐blind, non‐inferiority trial (<scp>STANDLOW</scp>)Giorgia Giussani, Simone Beretta, Elisa Bianchi et al.|Epilepsia Open|2025Cited by 0